Phenidylate en es it fr

Phenidylate Brand names, Phenidylate Analogs

Phenidylate Brand Names Mixture

  • No information avaliable

Phenidylate Chemical_Formula


Phenidylate RX_link

Phenidylate fda sheet

Phenidylate FDA

Phenidylate msds (material safety sheet)

Phenidylate MSDS

Phenidylate Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Phenidylate Molecular Weight

233.306 g/mol

Phenidylate Melting Point


Phenidylate H2O Solubility


Phenidylate State


Phenidylate LogP


Phenidylate Dosage Forms

Tablets; Tablets (sustained release)

Phenidylate Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Phenidylate Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Phenidylate Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Phenidylate side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Phenidylate Patient Information

Phenidylate Organisms Affected

Humans and other mammals